NICE final draft guidance recommending new drug faricimab to help treat two leading causes of sight loss and visual impairment
Faricimab is administered as an eye injection and is being recommended as an option for treating some adults with wet age-related macular degeneration (AMD) or with diabetic macular oedema (DMO).